HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Supplement Trade Interests Need U.S. Voice At Codex Mtgs. -Rep. Pallone

This article was originally published in The Tan Sheet

Executive Summary

A government trade expert familiar with dietary supplement issues should work with the U.S. Codex delegation to help ensure the principles of the Dietary Supplement Health & Education Act are upheld in Codex initiatives, House Government Reform Committee members suggested at a hearing March 20.

You may also be interested in...



U.S. Codex Likely To Advocate Voluntary Quantitative Food Labeling

Inclusion of quantitative ingredient information on prepackaged food labels should remain voluntary, food industry stakeholders tell Christine Lewis, PhD, the U.S. voting delegate to the Codex Committee on Food Labeling.

Codex

Upper limits for vitamin and mineral supplements one of several topics for which comments are requested by Elizabeth Yetley, PhD, CFSAN's lead nutrition scientist and U.S. delegate to the Codex Committee on Nutrition & Foods for Special Dietary Uses. Proposed Draft Guidelines for Vitamin and Mineral Supplements, Proposed Draft Revised Standard for Infant Formula and a discussion paper on risk-based approaches to nutrient intake assessment are subject to comment; deadline is Jan. 16. The documents, available on the U.S. Codex Web site, were drafted at the CCNFSDU meeting in Berlin in June; the full committee will gather again in Berlin Nov. 26-30

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS132586

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel